ObjectiveTo review the effects of core stability exercise or general exercise for patients with chronic low back pain (LBP).Summary of Background DataExercise therapy appears to be effective at decreasing pain and improving function for patients with chronic LBP in practice guidelines. Core stability exercise is becoming increasingly popular for LBP. However, it is currently unknown whether core stability exercise produces more beneficial effects than general exercise in patients with chronic LBP.MethodsPublished articles from 1970 to October 2011 were identified using electronic searches. For this meta-analysis, two reviewers independently selected relevant randomized controlled trials (RCTs) investigating core stability exercise versus general exercise for the treatment of patients with chronic LBP. Data were extracted independently by the same two individuals who selected the studies.ResultsFrom the 28 potentially relevant trials, a total of 5 trials involving 414 participants were included in the current analysis. The pooling revealed that core stability exercise was better than general exercise for reducing pain [mean difference (−1.29); 95% confidence interval (−2.47, −0.11); P = 0.003] and disability [mean difference (−7.14); 95% confidence interval (−11.64, −2.65); P = 0.002] at the time of the short-term follow-up. However, no significant differences were observed between core stability exercise and general exercise in reducing pain at 6 months [mean difference (−0.50); 95% confidence interval (−1.36, 0.36); P = 0.26] and 12 months [mean difference (−0.32); 95% confidence interval (−0.87, 0.23); P = 0.25].ConclusionsCompared to general exercise, core stability exercise is more effective in decreasing pain and may improve physical function in patients with chronic LBP in the short term. However, no significant long-term differences in pain severity were observed between patients who engaged in core stability exercise versus those who engaged in general exercise.Systematic Review Registration
http://www.crd.york.ac.uk/PROSPERO PROSPERO registration number: CRD42011001717.
An experiment was conducted to investigate the effect of dietary supplementation of xylo-oligosaccharides (XOS) on growth performance, meat quality, immune functions, duodenal morphology and intestinal microbial populations of broilers fed a conventional corn-soybean meal basal diet. A total of 450 1-d-old commercial Arbor Acres male broiler chicks were randomly allocated by bodyweight to 1 of 5 treatments with 6 replicate cages (15 broilers per cage) for each of 5 treatments in a completely randomized design. Chicks were fed the basal corn-soybean meal diets supplemented with 0, 25, 50, 75, or 100 mg of XOS kg-1 of diet, respectively for an experimental duration of 42 days. The results showed that supplementation of XOS affected feed conversion rate (feed/gain, F/G) during days 22-42 and 1-42 (P<0.03), drip loss in thigh muscle (P=0.02), and duodenal crypt depth (P=0.005) on day 42, but had no effect (P>0.05) on all other measured indices. The chicks fed the diet supplemented with 100 mg of XOS kg-1 had the lowest (P<0.05) F/G and drip loss in thigh muscle. The drip loss in thigh muscle decreased linearly (P=0.003) as the supplemented XOS increased. Duodenal crypt depth decreased (P<0.05) at the supplemental level of 75 mg of XOS kg-1. The results indicate that dietary supplementations of 75 and 100 mg of XOS kg-1 are beneficial to broilers fed a conventional corn-soybean meal diet.
The bionic fixation at least equals the performance of Endobutton fixation; it also allows more physiologic movement of the syndesmosis when compared to the screw fixation and may serve as a viable option for the fixation of the tibiofibular syndesmosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.